Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis

被引:1
|
作者
Wood, Marnie J. [1 ,2 ,3 ]
Powell, Lawrie W. [2 ,3 ,4 ,5 ,6 ]
Dixon, Jeannette L. [6 ]
Subramaniam, V. Nathan [2 ,7 ]
Ramm, Grant A. [1 ,2 ]
机构
[1] QIMR Berghofer Med Res Inst, Hepat Fibrosis Grp, Brisbane, Qld 4006, Australia
[2] Univ Queensland, Fac Med & Biomed Sci, Brisbane, Qld 4006, Australia
[3] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4029, Australia
[4] Royal Brisbane & Womens Hosp, Ctr Adv Clin Res, Brisbane, Qld 4029, Australia
[5] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia
[6] QIMR Berghofer Med Res Inst, Iron Metab Lab, Brisbane, Qld 4006, Australia
[7] QIMR Berghofer Med Res Inst, Membrane Transport Lab, Brisbane, Qld 4006, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Haemochromatosis; Genetic polymorphism; Liver fibrosis; Toll-like receptor 4; Interleukin; 10; Monocyte chemoattractant protein 1; Chemokine (C-C motif) ligand 2; Transforming growth factor beta; 8-oxoguanine DNA glycosylase; SINGLE NUCLEOTIDE POLYMORPHISMS; HFE HEREDITARY HEMOCHROMATOSIS; MONOCYTE CHEMOTACTIC PROTEIN-1; CHRONIC HEPATITIS-C; GENE POLYMORPHISM; LIVER-DISEASE; MCP-1; GENE; HEPATOCELLULAR-CARCINOMA; IL-10; LOCUS; INTERLEUKIN-10;
D O I
10.3748/wjg.v19.i48.9366
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the role of genetic polymorphisms in the progression of hepatic fibrosis in hereditary haemochromatosis. METHODS: A cohort of 245 well-characterised C282Y homozygous patients with haemochromatosis was studied, with all subjects having liver biopsy data and DNA available for testing. This study assessed the association of eight single nucleotide polymorphisms (SNPs) in a total of six genes including toll-like receptor 4 (TLR4), transforming growth factor-beta (TGF-beta), oxoguanine DNA glycosylase, monocyte chemoattractant protein 1, chemokine C-C motif receptor 2 and interleukin-10 with liver disease severity. Genotyping was performed using high resolution melt analysis and sequencing. The results were analysed in relation to the stage of hepatic fibrosis in multivariate analysis incorporating other cofactors including alcohol consumption and hepatic iron concentration. RESULTS: There were significant associations between the cofactors of male gender (P = 0.0001), increasing age (P = 0.006), alcohol consumption (P = 0.0001), steatosis (P = 0.03), hepatic iron concentration (P < 0.0001) and the presence of hepatic fibrosis. Of the candidate gene polymorphisms studied, none showed a significant association with hepatic fibrosis in univariate or multivariate analysis incorporating cofactors. We also specifically studied patients with hepatic iron loading above threshold levels for cirrhosis and compared the genetic polymorphisms between those with no fibrosis vs cirrhosis however there was no significant effect from any of the candidate genes studied. Importantly, in this large, well characterised cohort of patients there was no association between SNPs for TGF-beta or TLR4 and the presence of fibrosis, cirrhosis or increasing fibrosis stage in multivariate analysis. CONCLUSION: In our large, well characterised group of haemochromatosis subjects we did not demonstrate any relationship between candidate gene polymorphisms and hepatic fibrosis or cirrhosis. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:9366 / 9376
页数:11
相关论文
共 50 条
  • [1] Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis
    Marnie J Wood
    Lawrie W Powell
    Jeannette L Dixon
    V Nathan Subramaniam
    Grant A Ramm
    World Journal of Gastroenterology, 2013, 19 (48) : 9366 - 9376
  • [2] Relevance of Toll-like receptor-4 polymorphisms in renal transplantation
    Ducloux, D
    Deschamps, M
    Yannaraki, M
    Ferrand, C
    Bamoulid, J
    Saas, P
    Kazory, A
    Chalopin, JM
    Tiberghien, P
    KIDNEY INTERNATIONAL, 2005, 67 (06) : 2454 - 2461
  • [3] Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses A Novel Mechanism for Maintaining and Amplifying Fibrosis in Scleroderma
    Bhattacharyya, Swati
    Kelley, Kathleen
    Melichian, Denisa S.
    Tamaki, Zenshiro
    Fang, Feng
    Su, Yunyun
    Feng, Gilbert
    Pope, Richard M.
    Budinger, G. R. Scott
    Mutlu, Goekhan M.
    Lafyatis, Robert
    Radstake, Timothy
    Feghali-Bostwick, Carol
    Varga, John
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (01): : 192 - 205
  • [4] Effects of Toll-Like Receptor 4 Inhibition on Transforming Growth Factor-β2 Signaling in the Human Trabecular Meshwork
    Sharma, Tasneem P.
    Curry, Stacy
    McDowell, Colleen M.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (03) : 170 - 178
  • [5] Toll-like receptor-4 and allograft responses
    Samstein, B
    Johnson, GB
    Platt, JL
    TRANSPLANTATION, 2004, 77 (03) : 475 - 477
  • [6] Incidence of donor and recipient Toll-like receptor-4 polymorphisms in kidney transplantation
    Nogueira, E.
    Ozaki, K. S.
    Macusso, G. D.
    Quarim, R. F.
    Camara, N. O. S.
    Pacheco-Silva, A.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (02) : 412 - 414
  • [7] Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa
    Savva, A.
    Kanni, T.
    Damoraki, G.
    Kotsaki, A.
    Giatrakou, S.
    Grech, I.
    Katoulis, A.
    Papadavid, E.
    Giamarellos-Bourboulis, E. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (02) : 311 - 317
  • [8] Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice
    Canale-Zambrano, Juan C.
    Auger, Meagan L.
    Haston, Christina K.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 299 (02): : G381 - G390
  • [9] Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
    Pålsson-McDermott, EM
    O'Neill, LAJ
    IMMUNOLOGY, 2004, 113 (02) : 153 - 162
  • [10] Platelets Toll-like receptor-4 in Crohns disease
    Schmid, Werner
    Novacek, Gottfried
    Vogelsang, Harald
    Papay, Pavol
    Primas, Christian
    Eser, Alexander
    Panzer, Simon
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 (02) : 109 - 116